Michael Morneau, VP, Finance and Administration at Viking Therapeutics, Inc. (VKTX), sold 43,102 shares at $9.25 ($399K) on 2018-05-31, disclosed to the SEC on 2018-05-31.
Open-market sale of $399k VKTX by VP, Finance and Administration. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.25 | 21,551 | $199K | 50.0% |
| 2 | $9.25 | 21,551 | $199K | 50.0% |
| Total | $9.25 avg | 43,102 | $399K | 100% |
| Filing → |